Faster global financial news!
Merck
-
PwC, Merck, and Hashgraph launch a new provenance system for tracking cocoa, with plans to expand
The firms state their system, which combines physical authentication, digital traceability, and enterprise process design, is unprecedented in supply chains, and cocoa is just the initial application.
-
Moderna shares fall 7% to $135.22 as traders engage in profit-taking after a 392% year-to-date surge; BioNTech falls 4%, Merck falls 1%.
Moderna (MRNA) shares fell 7% to $135.22 in early trading Monday, after rising 392% year-to-date, as traders opted for profit-taking in the absence of new negative catalysts. Over the same period, Bio
-
Merck posts better-than-expected Q2 revenue of $16.61 billion, raises 2026 forecast on Keytruda strength
The U.S. drugmaker's Q2 revenue rose 5% year-over-year to $16.61 billion, surpassing analysts' average estimate of $16.36 billion. Sales of its top-selling cancer treatment Keytruda increased 5% to $8
-
PwC, Merck, and Hashgraph launch a new provenance system for tracking cocoa, with plans to expand
The firms state their system, which combines physical authentication, digital traceability, and enterprise process design, is unprecedented in supply chains, and cocoa is just the initial application.
-
Moderna shares fall 7% to $135.22 as traders engage in profit-taking after a 392% year-to-date surge; BioNTech falls 4%, Merck falls 1%.
Moderna (MRNA) shares fell 7% to $135.22 in early trading Monday, after rising 392% year-to-date, as traders opted for profit-taking in the absence of new negative catalysts. Over the same period, Bio
-
Merck posts better-than-expected Q2 revenue of $16.61 billion, raises 2026 forecast on Keytruda strength
The U.S. drugmaker's Q2 revenue rose 5% year-over-year to $16.61 billion, surpassing analysts' average estimate of $16.36 billion. Sales of its top-selling cancer treatment Keytruda increased 5% to $8
- No data
Merck
24H Trending
-
1
BofA Estimates: AI Infrastructure May Require $1.2 Trillion in External Financing Over Next 5 Years, With Over $300 Billion in Annual Incremental Debt Supply
-
2
Novo Nordisk, the Danish pharmaceutical giant, saw its shares fall by 7% despite setting a $23 billion sales target for its weight-loss drug.
-
3
JPMorgan CEO Dimon to Visit India This Week, Ramping Up Push for Deal Boom
-
4
Morgan Stanley’s Wilson Says US Stocks Risk 7% Drop in Near Term
-
5
XRP is testing the $1.50 resistance level, a key threshold that has capped its advances for roughly 230 days, with a break potentially leading to $1.80+
-
6
A Hong Kong hotel has been put up for sale by Nanyang Commercial Bank for HK$1.87 billion after being taken over, reflecting a trend of converting hotels into student dormitories.
-
7
Binance Stock Trading Platform Adds 25 New Stocks
-
8
Commodities trader Trafigura plans to float its supertanker arm Volare Shipping in Oslo, marking the business's first IPO
-
9
Seoul stocks rise 1.65% on chip gains despite Middle East tensions
-
10
US equity futures rise, led by AI stocks; oil prices fall over 2% to around $101; US Treasury yields decline; US and Chinese officials discuss AI national security "notification mechanism."
Markets Today
Recommended Reading
Hot Topics
Svmuu focuses on blockchain industry trends and cutting-edge cryptocurrency news, while also covering real-time market data and in-depth analysis of the Hong Kong, U.S., and foreign exchange markets. Here, you can not only access professional 24/7 news updates and accurate market data, but also utilize practical investment tools to help you capitalize on opportunities in both digital assets and traditional financial markets. Whether you are a blockchain enthusiast or an investor in Hong Kong, U.S., or foreign exchange markets, we provide efficient and timely information services to empower your investment decisions.
- User Agreement
- Privacy Policy
- Contact Us
- Business Partnerships
- Disclaimer
- Content Statement
- About Us
- Sitemap
Coming Soon!
